HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,289,952 | +3.1% | 14,400 | -2.0% | 0.03% | +7.1% |
| Q2 2023 | $1,251,558 | +12.9% | 14,700 | +9.7% | 0.03% | 0.0% |
| Q1 2023 | $1,108,850 | +104311.5% | 13,400 | -0.7% | 0.03% | -3.4% |
| Q4 2022 | $1,062 | -99.9% | 13,500 | -1.5% | 0.03% | -3.3% |
| Q3 2022 | $1,014,000 | +17.2% | 13,700 | +2.2% | 0.03% | +30.4% |
| Q2 2022 | $865,000 | +12.5% | 13,400 | 0.0% | 0.02% | +27.8% |
| Q1 2022 | $769,000 | +10.6% | 13,400 | +2.3% | 0.02% | +20.0% |
| Q4 2021 | $695,000 | -24.3% | 13,100 | +0.8% | 0.02% | -31.8% |
| Q3 2021 | $918,000 | +4.3% | 13,000 | -1.5% | 0.02% | +4.8% |
| Q2 2021 | $880,000 | -39.9% | 13,200 | 0.0% | 0.02% | -44.7% |
| Q1 2021 | $1,465,000 | -2.9% | 13,200 | +3.9% | 0.04% | -13.6% |
| Q4 2020 | $1,508,000 | +36.1% | 12,700 | 0.0% | 0.04% | -13.7% |
| Q3 2020 | $1,108,000 | -1.8% | 12,700 | +0.8% | 0.05% | -23.9% |
| Q2 2020 | $1,128,000 | -8.0% | 12,600 | +2.4% | 0.07% | -24.7% |
| Q1 2020 | $1,226,000 | -13.2% | 12,300 | 0.0% | 0.09% | +27.1% |
| Q4 2019 | $1,413,000 | -8.2% | 12,300 | +0.8% | 0.07% | -13.6% |
| Q3 2019 | $1,539,000 | -4.1% | 12,200 | -6.9% | 0.08% | 0.0% |
| Q2 2019 | $1,605,000 | +34.0% | 13,100 | -4.4% | 0.08% | +35.0% |
| Q1 2019 | $1,198,000 | -12.6% | 13,700 | 0.0% | 0.06% | -23.1% |
| Q4 2018 | $1,371,000 | -15.7% | 13,700 | -3.5% | 0.08% | +11.4% |
| Q3 2018 | $1,627,000 | +28.7% | 14,200 | +0.7% | 0.07% | +22.8% |
| Q2 2018 | $1,264,000 | -27.1% | 14,100 | -40.5% | 0.06% | -27.8% |
| Q1 2018 | $1,734,000 | +31.6% | 23,700 | +4.4% | 0.08% | +31.7% |
| Q4 2017 | $1,318,000 | +37.9% | 22,700 | +6.6% | 0.06% | +33.3% |
| Q3 2017 | $956,000 | +13.1% | 21,300 | -0.5% | 0.04% | +9.8% |
| Q2 2017 | $845,000 | -1.7% | 21,400 | +0.9% | 0.04% | -4.7% |
| Q1 2017 | $860,000 | +2.9% | 21,200 | +1.9% | 0.04% | 0.0% |
| Q4 2016 | $836,000 | +1.7% | 20,800 | -8.4% | 0.04% | 0.0% |
| Q3 2016 | $822,000 | +25.5% | 22,700 | +0.4% | 0.04% | +26.5% |
| Q2 2016 | $655,000 | -16.8% | 22,600 | +0.4% | 0.03% | -17.1% |
| Q1 2016 | $787,000 | +9.0% | 22,500 | +0.4% | 0.04% | +10.8% |
| Q4 2015 | $722,000 | -0.3% | 22,400 | 0.0% | 0.04% | 0.0% |
| Q3 2015 | $724,000 | -23.5% | 22,400 | -2.2% | 0.04% | -17.8% |
| Q2 2015 | $947,000 | -6.7% | 22,900 | +1.3% | 0.04% | -6.2% |
| Q1 2015 | $1,015,000 | +13.0% | 22,600 | -5.8% | 0.05% | +17.1% |
| Q4 2014 | $898,000 | +8.5% | 24,000 | +1.3% | 0.04% | +2.5% |
| Q3 2014 | $828,000 | -3.0% | 23,700 | -2.1% | 0.04% | 0.0% |
| Q2 2014 | $854,000 | +9.2% | 24,200 | +0.8% | 0.04% | +8.1% |
| Q1 2014 | $782,000 | -22.0% | 24,000 | +0.8% | 0.04% | -22.9% |
| Q4 2013 | $1,003,000 | – | 23,800 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |